Searched over 200M research papers
10 papers analyzed
These studies suggest A1C stands for hemoglobin A1c or glycated hemoglobin A1C.
19 papers analyzed
A1C stands for hemoglobin A1C, which is a form of hemoglobin that is chemically linked to glucose. This linkage occurs when glucose in the blood binds to hemoglobin, a protein in red blood cells that carries oxygen. The A1C test measures the percentage of hemoglobin that is glycated (bound to glucose), providing an average blood glucose level over the past two to three months .
Hemoglobin A1C is crucial for both diagnosing and managing diabetes mellitus. It helps in assessing long-term glycemic control, which is essential for preventing diabetes-related complications. The A1C test is widely used to judge the adequacy of diabetes treatment and to make necessary adjustments in therapy .
The accuracy of A1C measurements is vital for effective diabetes management. National and international standards have been established to minimize technical errors in A1C testing. The International Federation of Clinical Chemists (IFCC) has introduced a more precise measurement method, which has gained international acceptance. Despite these standards, various conditions can affect A1C levels, such as impaired erythrocyte production, altered glycation processes, patient ethnicity, and aging.
Several factors can falsely elevate or decrease A1C levels, making it less reliable in certain clinical scenarios. Conditions that impair red blood cell production or alter the glycation process can affect A1C results. Additionally, variations have been observed based on patient ethnicity and age.
To address these limitations, alternative methods for glucose evaluation are sometimes necessary. Continuous glucose monitoring (CGM) and self-monitoring of blood glucose (SMBG) are valuable tools that provide real-time glucose levels and trends, offering a more comprehensive picture of glycemic control .
The relationship between A1C and average glucose (AG) levels has been mathematically defined, allowing A1C to be expressed as estimated average glucose (eAG). This conversion helps patients and clinicians understand A1C results in the same units used for daily glucose monitoring, facilitating better diabetes management.
With the increasing use of CGM, the term "Glucose Management Indicator" (GMI) has been introduced to estimate A1C from CGM data. GMI provides an estimate of laboratory-measured A1C based on mean glucose readings from CGM, helping to bridge the gap between daily glucose monitoring and long-term glycemic control.
Hemoglobin A1C (A1C) is a critical marker for diagnosing and managing diabetes, providing an average blood glucose level over the past few months. While it is a valuable tool, various factors can affect its accuracy, necessitating alternative methods like CGM and SMBG for comprehensive glucose evaluation. Understanding the relationship between A1C and average glucose levels through measures like eAG and GMI can enhance diabetes management and patient education.
Most relevant research papers on this topic